Total Funding
3
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3071854
Virdante Pharmaceuticals is a biopharmaceutical company developing and commercializing drugs for autoimmune and inflammatory diseases.
Acquired by 
Momenta Pharmaceuticals
John Ripple: CEO
Jeffrey V. Ravetch: Scientific Founder and Chairman of the Scientific Advisory Board
About the Company
Virdante Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes drugs for autoimmune and inflammatory diseases. It offers antibody and Fc-fusion drugs to treat auto-immune diseases. The company was formerly known as Centaurus Pharmaceuticals and changed its name to Virdante Pharmaceuticals, Inc. in April, 2008. The company
was founded in 2007 and is based in Cambridge, Massachusetts.
